Click for best price
Active Transdermal Drug Delivery Device Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Active Transdermal Drug Delivery Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Active Transdermal Drug Delivery Device. This report contains market size and forecasts of Active Transdermal Drug Delivery Device in global, including the following market information:
Global Active Transdermal Drug Delivery Device Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Active Transdermal Drug Delivery Device Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five Active Transdermal Drug Delivery Device companies in 2022 (%)
The global Active Transdermal Drug Delivery Device market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Patches Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Active Transdermal Drug Delivery Device include Novartis AG, Noven Pharmaceuticals, Inc., Transdermal Corp., Johnson & Johnson (Janssen Pharmaceuticals Inc.), Mylan N.V., 3M, Actavis, Inc., Bayer AG and Boehringer Ingelheim GmbH, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Active Transdermal Drug Delivery Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Active Transdermal Drug Delivery Device Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Active Transdermal Drug Delivery Device Market Segment Percentages, by Type, 2022 (%)
Patches
Gels
Global Active Transdermal Drug Delivery Device Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Active Transdermal Drug Delivery Device Market Segment Percentages, by Application, 2022 (%)
Clinic
Hospital
Home Use
Global Active Transdermal Drug Delivery Device Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Active Transdermal Drug Delivery Device Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Active Transdermal Drug Delivery Device revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Active Transdermal Drug Delivery Device revenues share in global market, 2022 (%)
Key companies Active Transdermal Drug Delivery Device sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Active Transdermal Drug Delivery Device sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Noven Pharmaceuticals, Inc.
Transdermal Corp.
Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Mylan N.V.
3M
Actavis, Inc.
Bayer AG
Boehringer Ingelheim GmbH
Corium International, Inc.
Echo Therapeutics, Inc.
GlaxoSmithKline plc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Active Transdermal Drug Delivery Device, market overview.
Chapter 2: Global Active Transdermal Drug Delivery Device market size in revenue and volume.
Chapter 3: Detailed analysis of Active Transdermal Drug Delivery Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Active Transdermal Drug Delivery Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Active Transdermal Drug Delivery Device capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Active Transdermal Drug Delivery Device Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
71 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Active Transdermal Drug Delivery Device Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Active Transdermal Drug Delivery Device Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Active Transdermal Drug Delivery Device Overall Market Size
2.1 Global Active Transdermal Drug Delivery Device Market Size: 2022 VS 2030
2.2 Global Active Transdermal Drug Delivery Device Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Active Transdermal Drug Delivery Device Sales: 2018-2030
3 Company Landscape
3.1 Top Active Transdermal Drug Delivery Device Players in Global Market
3.2 Top Global Active Transdermal Drug Delivery Device Companies Ranked by Revenue
3.3 Global Active Transdermal Drug Delivery Device Revenue by Companies
3.4 Global Active Transdermal Drug Delivery Device Sales by Companies
3.5 Global Active Transdermal Drug Delivery Device Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Active Transdermal Drug Delivery Device Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Active Transdermal Drug Delivery Device Product Type
3.8 Tier 1, Tier 2 and Tier 3 Active Transdermal Drug Delivery Device Players in Global Market
3.8.1 List of Global Tier 1 Active Transdermal Drug Delivery Device Companies
3.8.2 List of Global Tier 2 and Tier 3 Active Transdermal Drug Delivery Device Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Active Transdermal Drug Delivery Device Market Size Markets, 2022 & 2030
4.1.2 Patches
4.1.3 Gels
4.2 By Type - Global Active Transdermal Drug Delivery Device Revenue & Forecasts
4.2.1 By Type - Global Active Transdermal Drug Delivery Device Revenue, 2018-2023
4.2.2 By Type - Global Active Transdermal Drug Delivery Device Revenue, 2024-2030
4.2.3 By Type - Global Active Transdermal Drug Delivery Device Revenue Market Share, 2018-2030
4.3 By Type - Global Active Transdermal Drug Delivery Device Sales & Forecasts
4.3.1 By Type - Global Active Transdermal Drug Delivery Device Sales, 2018-2023
4.3.2 By Type - Global Active Transdermal Drug Delivery Device Sales, 2024-2030
4.3.3 By Type - Global Active Transdermal Drug Delivery Device Sales Market Share, 2018-2030
4.4 By Type - Global Active Transdermal Drug Delivery Device Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Active Transdermal Drug Delivery Device Market Size, 2022 & 2030
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Home Use
5.2 By Application - Global Active Transdermal Drug Delivery Device Revenue & Forecasts
5.2.1 By Application - Global Active Transdermal Drug Delivery Device Revenue, 2018-2023
5.2.2 By Application - Global Active Transdermal Drug Delivery Device Revenue, 2024-2030
5.2.3 By Application - Global Active Transdermal Drug Delivery Device Revenue Market Share, 2018-2030
5.3 By Application - Global Active Transdermal Drug Delivery Device Sales & Forecasts
5.3.1 By Application - Global Active Transdermal Drug Delivery Device Sales, 2018-2023
5.3.2 By Application - Global Active Transdermal Drug Delivery Device Sales, 2024-2030
5.3.3 By Application - Global Active Transdermal Drug Delivery Device Sales Market Share, 2018-2030
5.4 By Application - Global Active Transdermal Drug Delivery Device Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Active Transdermal Drug Delivery Device Market Size, 2022 & 2030
6.2 By Region - Global Active Transdermal Drug Delivery Device Revenue & Forecasts
6.2.1 By Region - Global Active Transdermal Drug Delivery Device Revenue, 2018-2023
6.2.2 By Region - Global Active Transdermal Drug Delivery Device Revenue, 2024-2030
6.2.3 By Region - Global Active Transdermal Drug Delivery Device Revenue Market Share, 2018-2030
6.3 By Region - Global Active Transdermal Drug Delivery Device Sales & Forecasts
6.3.1 By Region - Global Active Transdermal Drug Delivery Device Sales, 2018-2023
6.3.2 By Region - Global Active Transdermal Drug Delivery Device Sales, 2024-2030
6.3.3 By Region - Global Active Transdermal Drug Delivery Device Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Active Transdermal Drug Delivery Device Revenue, 2018-2030
6.4.2 By Country - North America Active Transdermal Drug Delivery Device Sales, 2018-2030
6.4.3 US Active Transdermal Drug Delivery Device Market Size, 2018-2030
6.4.4 Canada Active Transdermal Drug Delivery Device Market Size, 2018-2030
6.4.5 Mexico Active Transdermal Drug Delivery Device Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Active Transdermal Drug Delivery Device Revenue, 2018-2030
6.5.2 By Country - Europe Active Transdermal Drug Delivery Device Sales, 2018-2030
6.5.3 Germany Active Transdermal Drug Delivery Device Market Size, 2018-2030
6.5.4 France Active Transdermal Drug Delivery Device Market Size, 2018-2030
6.5.5 U.K. Active Transdermal Drug Delivery Device Market Size, 2018-2030
6.5.6 Italy Active Transdermal Drug Delivery Device Market Size, 2018-2030
6.5.7 Russia Active Transdermal Drug Delivery Device Market Size, 2018-2030
6.5.8 Nordic Countries Active Transdermal Drug Delivery Device Market Size, 2018-2030
6.5.9 Benelux Active Transdermal Drug Delivery Device Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Active Transdermal Drug Delivery Device Revenue, 2018-2030
6.6.2 By Region - Asia Active Transdermal Drug Delivery Device Sales, 2018-2030
6.6.3 China Active Transdermal Drug Delivery Device Market Size, 2018-2030
6.6.4 Japan Active Transdermal Drug Delivery Device Market Size, 2018-2030
6.6.5 South Korea Active Transdermal Drug Delivery Device Market Size, 2018-2030
6.6.6 Southeast Asia Active Transdermal Drug Delivery Device Market Size, 2018-2030
6.6.7 India Active Transdermal Drug Delivery Device Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Active Transdermal Drug Delivery Device Revenue, 2018-2030
6.7.2 By Country - South America Active Transdermal Drug Delivery Device Sales, 2018-2030
6.7.3 Brazil Active Transdermal Drug Delivery Device Market Size, 2018-2030
6.7.4 Argentina Active Transdermal Drug Delivery Device Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Active Transdermal Drug Delivery Device Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Active Transdermal Drug Delivery Device Sales, 2018-2030
6.8.3 Turkey Active Transdermal Drug Delivery Device Market Size, 2018-2030
6.8.4 Israel Active Transdermal Drug Delivery Device Market Size, 2018-2030
6.8.5 Saudi Arabia Active Transdermal Drug Delivery Device Market Size, 2018-2030
6.8.6 UAE Active Transdermal Drug Delivery Device Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Active Transdermal Drug Delivery Device Major Product Offerings
7.1.4 Novartis AG Active Transdermal Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Noven Pharmaceuticals, Inc.
7.2.1 Noven Pharmaceuticals, Inc. Company Summary
7.2.2 Noven Pharmaceuticals, Inc. Business Overview
7.2.3 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Major Product Offerings
7.2.4 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.2.5 Noven Pharmaceuticals, Inc. Key News & Latest Developments
7.3 Transdermal Corp.
7.3.1 Transdermal Corp. Company Summary
7.3.2 Transdermal Corp. Business Overview
7.3.3 Transdermal Corp. Active Transdermal Drug Delivery Device Major Product Offerings
7.3.4 Transdermal Corp. Active Transdermal Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.3.5 Transdermal Corp. Key News & Latest Developments
7.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
7.4.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Company Summary
7.4.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Business Overview
7.4.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Major Product Offerings
7.4.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.4.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Key News & Latest Developments
7.5 Mylan N.V.
7.5.1 Mylan N.V. Company Summary
7.5.2 Mylan N.V. Business Overview
7.5.3 Mylan N.V. Active Transdermal Drug Delivery Device Major Product Offerings
7.5.4 Mylan N.V. Active Transdermal Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.5.5 Mylan N.V. Key News & Latest Developments
7.6 3M
7.6.1 3M Company Summary
7.6.2 3M Business Overview
7.6.3 3M Active Transdermal Drug Delivery Device Major Product Offerings
7.6.4 3M Active Transdermal Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.6.5 3M Key News & Latest Developments
7.7 Actavis, Inc.
7.7.1 Actavis, Inc. Company Summary
7.7.2 Actavis, Inc. Business Overview
7.7.3 Actavis, Inc. Active Transdermal Drug Delivery Device Major Product Offerings
7.7.4 Actavis, Inc. Active Transdermal Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.7.5 Actavis, Inc. Key News & Latest Developments
7.8 Bayer AG
7.8.1 Bayer AG Company Summary
7.8.2 Bayer AG Business Overview
7.8.3 Bayer AG Active Transdermal Drug Delivery Device Major Product Offerings
7.8.4 Bayer AG Active Transdermal Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.8.5 Bayer AG Key News & Latest Developments
7.9 Boehringer Ingelheim GmbH
7.9.1 Boehringer Ingelheim GmbH Company Summary
7.9.2 Boehringer Ingelheim GmbH Business Overview
7.9.3 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Major Product Offerings
7.9.4 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.9.5 Boehringer Ingelheim GmbH Key News & Latest Developments
7.10 Corium International, Inc.
7.10.1 Corium International, Inc. Company Summary
7.10.2 Corium International, Inc. Business Overview
7.10.3 Corium International, Inc. Active Transdermal Drug Delivery Device Major Product Offerings
7.10.4 Corium International, Inc. Active Transdermal Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.10.5 Corium International, Inc. Key News & Latest Developments
7.11 Echo Therapeutics, Inc.
7.11.1 Echo Therapeutics, Inc. Company Summary
7.11.2 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Business Overview
7.11.3 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Major Product Offerings
7.11.4 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.11.5 Echo Therapeutics, Inc. Key News & Latest Developments
7.12 GlaxoSmithKline plc
7.12.1 GlaxoSmithKline plc Company Summary
7.12.2 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Business Overview
7.12.3 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Major Product Offerings
7.12.4 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.12.5 GlaxoSmithKline plc Key News & Latest Developments
8 Global Active Transdermal Drug Delivery Device Production Capacity, Analysis
8.1 Global Active Transdermal Drug Delivery Device Production Capacity, 2018-2030
8.2 Active Transdermal Drug Delivery Device Production Capacity of Key Manufacturers in Global Market
8.3 Global Active Transdermal Drug Delivery Device Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Active Transdermal Drug Delivery Device Supply Chain Analysis
10.1 Active Transdermal Drug Delivery Device Industry Value Chain
10.2 Active Transdermal Drug Delivery Device Upstream Market
10.3 Active Transdermal Drug Delivery Device Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Active Transdermal Drug Delivery Device Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Active Transdermal Drug Delivery Device in Global Market
Table 2. Top Active Transdermal Drug Delivery Device Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Active Transdermal Drug Delivery Device Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Active Transdermal Drug Delivery Device Revenue Share by Companies, 2018-2023
Table 5. Global Active Transdermal Drug Delivery Device Sales by Companies, (K Units), 2018-2023
Table 6. Global Active Transdermal Drug Delivery Device Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Active Transdermal Drug Delivery Device Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Active Transdermal Drug Delivery Device Product Type
Table 9. List of Global Tier 1 Active Transdermal Drug Delivery Device Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Active Transdermal Drug Delivery Device Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Active Transdermal Drug Delivery Device Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Active Transdermal Drug Delivery Device Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Active Transdermal Drug Delivery Device Sales (K Units), 2018-2023
Table 15. By Type - Global Active Transdermal Drug Delivery Device Sales (K Units), 2024-2030
Table 16. By Application ? Global Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Active Transdermal Drug Delivery Device Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Active Transdermal Drug Delivery Device Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Active Transdermal Drug Delivery Device Sales (K Units), 2018-2023
Table 20. By Application - Global Active Transdermal Drug Delivery Device Sales (K Units), 2024-2030
Table 21. By Region ? Global Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Active Transdermal Drug Delivery Device Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Active Transdermal Drug Delivery Device Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Active Transdermal Drug Delivery Device Sales (K Units), 2018-2023
Table 25. By Region - Global Active Transdermal Drug Delivery Device Sales (K Units), 2024-2030
Table 26. By Country - North America Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Active Transdermal Drug Delivery Device Sales, (K Units), 2018-2023
Table 29. By Country - North America Active Transdermal Drug Delivery Device Sales, (K Units), 2024-2030
Table 30. By Country - Europe Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Active Transdermal Drug Delivery Device Sales, (K Units), 2018-2023
Table 33. By Country - Europe Active Transdermal Drug Delivery Device Sales, (K Units), 2024-2030
Table 34. By Region - Asia Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Active Transdermal Drug Delivery Device Sales, (K Units), 2018-2023
Table 37. By Region - Asia Active Transdermal Drug Delivery Device Sales, (K Units), 2024-2030
Table 38. By Country - South America Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Active Transdermal Drug Delivery Device Sales, (K Units), 2018-2023
Table 41. By Country - South America Active Transdermal Drug Delivery Device Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Active Transdermal Drug Delivery Device Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Active Transdermal Drug Delivery Device Sales, (K Units), 2024-2030
Table 46. Novartis AG Company Summary
Table 47. Novartis AG Active Transdermal Drug Delivery Device Product Offerings
Table 48. Novartis AG Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Novartis AG Key News & Latest Developments
Table 50. Noven Pharmaceuticals, Inc. Company Summary
Table 51. Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Product Offerings
Table 52. Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Noven Pharmaceuticals, Inc. Key News & Latest Developments
Table 54. Transdermal Corp. Company Summary
Table 55. Transdermal Corp. Active Transdermal Drug Delivery Device Product Offerings
Table 56. Transdermal Corp. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Transdermal Corp. Key News & Latest Developments
Table 58. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Company Summary
Table 59. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Product Offerings
Table 60. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Key News & Latest Developments
Table 62. Mylan N.V. Company Summary
Table 63. Mylan N.V. Active Transdermal Drug Delivery Device Product Offerings
Table 64. Mylan N.V. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Mylan N.V. Key News & Latest Developments
Table 66. 3M Company Summary
Table 67. 3M Active Transdermal Drug Delivery Device Product Offerings
Table 68. 3M Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. 3M Key News & Latest Developments
Table 70. Actavis, Inc. Company Summary
Table 71. Actavis, Inc. Active Transdermal Drug Delivery Device Product Offerings
Table 72. Actavis, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Actavis, Inc. Key News & Latest Developments
Table 74. Bayer AG Company Summary
Table 75. Bayer AG Active Transdermal Drug Delivery Device Product Offerings
Table 76. Bayer AG Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Bayer AG Key News & Latest Developments
Table 78. Boehringer Ingelheim GmbH Company Summary
Table 79. Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Product Offerings
Table 80. Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Boehringer Ingelheim GmbH Key News & Latest Developments
Table 82. Corium International, Inc. Company Summary
Table 83. Corium International, Inc. Active Transdermal Drug Delivery Device Product Offerings
Table 84. Corium International, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Corium International, Inc. Key News & Latest Developments
Table 86. Echo Therapeutics, Inc. Company Summary
Table 87. Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Product Offerings
Table 88. Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Echo Therapeutics, Inc. Key News & Latest Developments
Table 90. GlaxoSmithKline plc Company Summary
Table 91. GlaxoSmithKline plc Active Transdermal Drug Delivery Device Product Offerings
Table 92. GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. GlaxoSmithKline plc Key News & Latest Developments
Table 94. Active Transdermal Drug Delivery Device Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 95. Global Active Transdermal Drug Delivery Device Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global Active Transdermal Drug Delivery Device Production by Region, 2018-2023 (K Units)
Table 97. Global Active Transdermal Drug Delivery Device Production by Region, 2024-2030 (K Units)
Table 98. Active Transdermal Drug Delivery Device Market Opportunities & Trends in Global Market
Table 99. Active Transdermal Drug Delivery Device Market Drivers in Global Market
Table 100. Active Transdermal Drug Delivery Device Market Restraints in Global Market
Table 101. Active Transdermal Drug Delivery Device Raw Materials
Table 102. Active Transdermal Drug Delivery Device Raw Materials Suppliers in Global Market
Table 103. Typical Active Transdermal Drug Delivery Device Downstream
Table 104. Active Transdermal Drug Delivery Device Downstream Clients in Global Market
Table 105. Active Transdermal Drug Delivery Device Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Active Transdermal Drug Delivery Device Segment by Type in 2022
Figure 2. Active Transdermal Drug Delivery Device Segment by Application in 2022
Figure 3. Global Active Transdermal Drug Delivery Device Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Active Transdermal Drug Delivery Device Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Active Transdermal Drug Delivery Device Revenue, 2018-2030 (US$, Mn)
Figure 7. Active Transdermal Drug Delivery Device Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Active Transdermal Drug Delivery Device Revenue in 2022
Figure 9. By Type - Global Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Active Transdermal Drug Delivery Device Revenue Market Share, 2018-2030
Figure 11. By Type - Global Active Transdermal Drug Delivery Device Sales Market Share, 2018-2030
Figure 12. By Type - Global Active Transdermal Drug Delivery Device Price (USD/Unit), 2018-2030
Figure 13. By Application - Global Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Active Transdermal Drug Delivery Device Revenue Market Share, 2018-2030
Figure 15. By Application - Global Active Transdermal Drug Delivery Device Sales Market Share, 2018-2030
Figure 16. By Application - Global Active Transdermal Drug Delivery Device Price (USD/Unit), 2018-2030
Figure 17. By Region - Global Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Active Transdermal Drug Delivery Device Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Active Transdermal Drug Delivery Device Revenue Market Share, 2018-2030
Figure 20. By Region - Global Active Transdermal Drug Delivery Device Sales Market Share, 2018-2030
Figure 21. By Country - North America Active Transdermal Drug Delivery Device Revenue Market Share, 2018-2030
Figure 22. By Country - North America Active Transdermal Drug Delivery Device Sales Market Share, 2018-2030
Figure 23. US Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Active Transdermal Drug Delivery Device Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Active Transdermal Drug Delivery Device Sales Market Share, 2018-2030
Figure 28. Germany Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 29. France Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Active Transdermal Drug Delivery Device Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Active Transdermal Drug Delivery Device Sales Market Share, 2018-2030
Figure 37. China Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 41. India Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Active Transdermal Drug Delivery Device Revenue Market Share, 2018-2030
Figure 43. By Country - South America Active Transdermal Drug Delivery Device Sales Market Share, 2018-2030
Figure 44. Brazil Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Active Transdermal Drug Delivery Device Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Active Transdermal Drug Delivery Device Sales Market Share, 2018-2030
Figure 48. Turkey Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 52. Global Active Transdermal Drug Delivery Device Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Active Transdermal Drug Delivery Device by Region, 2022 VS 2030
Figure 54. Active Transdermal Drug Delivery Device Industry Value Chain
Figure 55. Marketing Channels
